Dalbavancin hydrochloride is a lipoglycopeptide antibacterial used to treat Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in adults and children caused by Gram-positive bacteria, including MRSA. It is given as a long-acting intravenous infusion, typically as a single dose or two doses one week apart, allowing for outpatient treatment. It is grouped under the following drug class(es): Glycopeptides and Peptides. Its therapeutic use is listed as antibacterials. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Dalvance and Xydalba. Its PubChem CID is 86298757.
Dalbavancin hydrochloride
| CAS No | 2227366-51-8 |
|---|---|
| Molecular Formula | C88H101Cl3N10O28 |
| Molecular Weight | 1853.1 g/mol |
| Synonyms | (2S,3S,4R,5R,6S)-6-[[(1S,2R,19R,22R,34S,37R,40R,52S)-5,32-dichloro-52-[3-(dimethylamino)propylcarbamoyl]-2,26,31,44,49-pentahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,65-henicosaen-64-yl]oxy]-3,4-dihydroxy-5-(10-methylundecanoylamino)oxane-2-carboxylic acid;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dalbavancin hydrochloride is a lipoglycopeptide antibacterial used to treat Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in adults and children caused by Gram-positive bacteria, including MRSA.
The listed CAS number is 2227366-51-8.
The listed molecular formula is C88H101Cl3N10O28.
The listed molecular weight is 1853.1 g/mol.
The source lists Dalvance and Xydalba.
Its therapeutic use is listed as antibacterials.